Curriculum · Nephrology and Urology
Post-streptococcal glomerulonephritis
What it is
Poststreptococcal glomerulonephritis is the classic example of acute glomerulonephritis, which may be due to a variety of immunologic, infectious or postinfectious causes. It presents as nephritic syndrome, one of the two clinical manifestations of glomerular disease, and it is the most common cause of nephritic syndrome in children.
It occurs after infection with a group A beta haemolytic streptococcal infection of the upper respiratory tract, or of the skin, that is impetigo, usually Streptococcus pyogenes. The GN develops about 10 to 14 days after the infection, put elsewhere as typically 7-14 days following it. It is caused by immune complex deposition, IgG, IgM and C3, in the glomeruli, and it primarily affects children, ages 2 to 6, with young children most affected. It is one of the listed complications of scarlet fever, alongside acute rheumatic fever.
The interval is not one number but two, and it follows the site of the infection: after pharyngitis or tonsillitis, which is the most common, it is 1-2 weeks, and after skin infections it is 3-4 weeks. The age band is reported as ages 2 to 6 in one source and as children between the ages of 3-12 years in another.
Causes and risk
The rest of the nephritic list is IgA nephropathy, also called Berger disease, granulomatosis with polyangiitis, microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis, Goodpasture syndrome or anti-GBM disease, Alport syndrome or hereditary nephritis, thin basement membrane disease, rapidly progressive glomerulonephritis and lupus nephritis. Membranoproliferative glomerulonephritis is the most common cause of the mixed nephritic-nephrotic picture. Among the vasculitides, granulomatosis with polyangiitis is a pauci-immune glomerulonephritis with the triad of systemic vasculitis, upper and lower airway granulomatous inflammation, and glomerulonephritis, and it shows RBC casts and proteinuria with c-ANCA; its differential includes Goodpasture's syndrome with anti-GBM and Churg-Strauss syndrome with p-ANCA. Polyarteritis nodosa is listed on the differential of Churg-Strauss syndrome itself, together with Wegener's granulomatosis with c-ANCA. Microscopic polyangiitis is p-ANCA positive.
The others on that list separate by their own findings. IgA nephropathy is the most common idiopathic glomerulonephritis worldwide, with episodic gross hematuria during or directly after upper respiratory tract or gastrointestinal infections or strenuous exercise, a peak incidence in the second to third decade of life, and 25-30% of patients progressing to end-stage renal disease within 20-25 years; its findings are asymptomatic microhematuria with intermittent gross hematuria, a raised serum IgA, normal C3 complement levels, mesangial proliferation on light microscopy and mesangial IgA deposits. Granulomatosis with polyangiitis has common pulmonary and nasopharyngeal involvement with hemoptysis and nasal ulcers, c-ANCA, and a renal biopsy showing segmental necrotizing glomerulonephritis, or crescentic glomerulonephritis with cellular crescents in more than half of the glomeruli. Microscopic polyangiitis usually has only mild respiratory symptoms and is p-ANCA positive. Churg-Strauss syndrome presents with asthma, purpura and peripheral neuropathy, with p-ANCA in about 50% of cases, peripheral eosinophilia and a focal segmental necrotizing glomerulonephritis. Goodpasture syndrome has two peaks of occurrence, the third decade of life and above 60 years of age, is caused by antibodies against type IV collagen that cross-react with the basement membrane of the pulmonary capillaries to give pulmonary hemorrhage and hemoptysis, and shows pulmonary infiltrates on chest x-ray with linear deposition of IgG along the glomerular basement membrane. Thin basement membrane disease is a hereditary disorder of type IV collagen with a good prognosis, persistent microhematuria and diffuse thinning of the glomerular basement membrane on EM. Their treatments differ as well: supportive therapy for IgA nephropathy with glucocorticoids in severe cases, immunosuppressive therapy for the ANCA vasculitides, immunosuppressive therapy with plasmapheresis for Goodpasture syndrome, and renal function monitoring with supportive therapy for thin basement membrane disease.